| GTO ID | GTC0911 |
| Trial ID | ChiCTR2100042272 |
| Disease | Myelodysplastic Syndrome | Acute Leukemia |
| Altered gene | CMV |
| Therapeutic/Target gene | Target gene |
| Therapy | TCR-T cell |
| Treatment | CMV TCR-T cells |
| Phase | Early_Phase1 |
| Recruitment status | Not Recruiting |
| Title | A study of CMV-TCR-T cells in the treatment of refractory CMVemia after HSCT |
| Year | 2021 |
| Country | China |
| Company sponsor | Peking University People's Hospital |
| Cohort 1 | |||||||
|
|||||||